Broadhurst Vanessa
SEC CIK 1904787 · EDGAR
BoughtSold
Most active insiders at JNJ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duato Joaquin | CEO, COB, Dir | — | $66.84M |
| 2 | Wolk Joseph J | EVP, CFO | — | $21.77M |
| 3 | REED JOHN C | EVP, Innovative Medicine, R, D | — | $17.29M |
| 4 | Swanson James D. | EVP, CIO | — | $15.11M |
| 5 | Schmid Timothy | EVP, WW COB, MedTech | — | $15.08M |
| 6 | Broadhurst Vanessa | EVP, Gbl Corp Affairs | — | $7.30M |
| 7 | Forminard Elizabeth | EVP, CLO | — | $4.09M |
| 8 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | — | $3.95M |
| 9 | Wengel Kathryn E | EVP, Chief TO, Risk Off | — | $2.41M |
| 10 | Decker Robert J | VP Corp. Ctrl | — | $1.01M |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-07-21 17:27 | 2026-07-20 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $130.77 | +23.1K | 46.1K | +100% | +$3.01M |
| D | 2026-07-21 17:27 | 2026-07-20 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | S - Sale+OE | $251.27 | -23.1K | 23.0K | -50% | -$5.79M |
| D | 2026-02-23 | 2026-02-19 | ZTS | Zoetis | Broadhurst Vanessa | Dir | M - OptEx | — | +1,619 | 4,437 | +57% | — |
| D | 2026-02-23 | 2026-02-19 | ZTS | Zoetis | Broadhurst Vanessa | Dir | J - Other | $127.28 | -517 | 3,920 | -12% | -$65.8K |
| DM | 2026-02-18 21:11 | 2026-02-13+ | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +10.0K | 29.5K | +52% | $0 |
| DM | 2026-02-18 21:11 | 2026-02-13+ | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $244.42 | -4,414 | 29.2K | -13% | -$1.08M |
| D | 2026-02-18 21:11 | 2026-02-17 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | S - Sale+OE | $243.39 | -6,197 | 23.0K | -21% | -$1.51M |
| D | 2025-07-28 | 2025-07-25 | ZTS | Zoetis | Broadhurst Vanessa | Dir | M - OptEx | — | +1,412 | 3,269 | +76% | — |
| D | 2025-07-28 | 2025-07-25 | ZTS | Zoetis | Broadhurst Vanessa | Dir | J - Other | $152.12 | -451 | 2,818 | -14% | -$68.6K |
| DM | 2025-02-18 20:58 | 2025-02-13+ | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +5,640 | 24.6K | +30% | $0 |
| DM | 2025-02-18 20:58 | 2025-02-14+ | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $156.55 | -1,880 | 23.6K | -7% | -$294.3K |
| D | 2025-02-10 | 2025-02-06 | ZTS | Zoetis | Broadhurst Vanessa | Dir | J - Other | $174.12 | -395 | 1,857 | -18% | -$68.8K |
| D | 2025-02-10 | 2025-02-06 | ZTS | Zoetis | Broadhurst Vanessa | Dir | M - OptEx | — | +1,236 | 2,252 | +122% | — |
| D | 2024-07-09 17:48 | 2024-07-08 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +9,809 | 24.9K | +65% | $0 |
| D | 2024-07-09 17:48 | 2024-07-08 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $147.16 | -5,018 | 19.8K | -20% | -$738.4K |
| 2024-03-13 16:36 | 2024-03-13 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | S - Sale | $162.16 | -8,891 | 15.0K | -37% | -$1.44M | |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +408 | 24.1K | +2% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $157.85 | -209 | 23.9K | -0.9% | -$33.0K |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +4,701 | 25.1K | +23% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | A - Grant | $0.00 | +790 | 25.9K | +3% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $157.40 | -2,136 | 23.7K | -8% | -$336.2K |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +1,880 | 21.1K | +10% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $156.33 | -703 | 20.4K | -3% | -$109.9K |
| D | 2024-02-12 | 2024-02-08 | ZTS | Zoetis | Broadhurst Vanessa | Dir | J - Other | $195.75 | -477 | 1,016 | -32% | -$93.4K |
| D | 2024-02-12 | 2024-02-08 | ZTS | Zoetis | Broadhurst Vanessa | Dir | M - OptEx | — | +1,493 | 1,493 | New | — |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | A - Grant | $0.00 | +3,981 | 20.6K | +24% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $162.01 | -1,440 | 19.2K | -7% | -$233.3K |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +1,592 | 17.3K | +10% | $0 |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $162.08 | -597 | 16.7K | -3% | -$96.8K |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Aff | M - OptEx | $0.00 | +2,557 | 16.6K | +18% | $0 |
| D | 2022-02-17 06:00 | 2022-02-15 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Aff | F - Tax | $165.89 | -925 | 15.7K | -6% | -$153.4K |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Aff | M - OptEx | $0.00 | +2,451 | 14.9K | +20% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Johnson & Johnson | Broadhurst Vanessa | EVP, Gbl Corp Aff | F - Tax | $168.85 | -902 | 14.0K | -6% | -$152.3K |
Purchase Sale Sale after option exercise All abbreviations